Renbin Zhao

2.0k total citations · 1 hit paper
37 papers, 1.5k citations indexed

About

Renbin Zhao is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Renbin Zhao has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Renbin Zhao's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and RNA modifications and cancer (5 papers). Renbin Zhao is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and RNA modifications and cancer (5 papers). Renbin Zhao collaborates with scholars based in China, United States and Australia. Renbin Zhao's co-authors include David H. Mack, Maureen E. Murphy, William H. Hoffman, Yuxin Yin, Kurt Gish, Arnold J. Levine, Daniel A. Notterman, Edward Tom, Michael F. Seldin and John F. Fallon and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Blood.

In The Last Decade

Renbin Zhao

35 papers receiving 1.5k citations

Hit Papers

Analysis of p53-regulated gene expression patterns using ... 2000 2026 2008 2017 2000 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
    2000 538 citations Renbin Zhao, Kurt Gish et al. profile →

Peers

Renbin Zhao
Doris A. Phelps United States
Susanne Meyer Germany
Ge Zhou United States
Nigel J. O’Neil Canada
Rosa Luna Spain
Hestia Mellert United States
Elaine Sanij Australia
Virginie Marcel France
Jolly Mazumdar United States
Arnaud Coquelle France
Doris A. Phelps United States
Renbin Zhao
Citations per year, relative to Renbin Zhao Renbin Zhao (= 1×) peers Doris A. Phelps

Countries citing papers authored by Renbin Zhao

Since Specialization
Citations

This map shows the geographic impact of Renbin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renbin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renbin Zhao more than expected).

Fields of papers citing papers by Renbin Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renbin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renbin Zhao. The network helps show where Renbin Zhao may publish in the future.

Co-authorship network of co-authors of Renbin Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Renbin Zhao. A scholar is included among the top collaborators of Renbin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renbin Zhao. Renbin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhongyu, et al.. (2025). Molecular pathology of lymphoma and its treatment strategies: from mechanistic elucidation to precision medicine. Frontiers in Immunology. 16. 1620895–1620895. 1 indexed citations
2.
Geng, Jiawei, Bin Han, Shuai Feng, et al.. (2025). The type of pathogen is associated with organ failure and legacy dysfunction in patients with sepsis. Frontiers in Immunology. 16. 1541634–1541634. 1 indexed citations
3.
Zhang, Chaoran, Peng Hu, Jinping Zhang, et al.. (2023). Expression of Th1/2/17 Cytokines in CML with or without Pulmonary Bacterial and Fungal Coinfection. Journal of Oncology. 2023. 1–10. 2 indexed citations
4.
Song, Ying, et al.. (2023). Changes in expression levels of immune cells and inflammatory cytokines in pre-eclampsia patients before and after delivery. Journal of Reproductive Immunology. 156. 103812–103812. 2 indexed citations
5.
Zhang, Jinping, Peng Hu, Chaoran Zhang, et al.. (2022). Cytokines help suggest aplastic anemia with pulmonary bacterial or co-fungal infection. Scientific Reports. 12(1). 18373–18373. 5 indexed citations
6.
Zhang, Lihua, Jinping Zhang, Haiping He, et al.. (2022). Increased Cytokine Levels Assist in the Diagnosis of Respiratory Bacterial Infections or Concurrent Bacteremia in Patients With Non-Hodgkin’s Lymphoma. Frontiers in Cellular and Infection Microbiology. 12. 860526–860526. 9 indexed citations
7.
Cao, Xinxin, Jie Jin, Chengcheng Fu, et al.. (2022). Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study. EClinicalMedicine. 52. 101682–101682. 26 indexed citations
8.
9.
Wei, Xiaoli, Feng‐Hua Wang, Xiaochen Zhang, et al.. (2022). Safety, pharmacokinetics (PK), and clinical efficacy of ICP-723, a highly selective next-generation pan-TRK inhibitor, in patients with solid tumor.. Journal of Clinical Oncology. 40(16_suppl). 3106–3106. 3 indexed citations
10.
Qin, Yanru, Aimin Zang, Lijuan Yang, et al.. (2021). 840P Preliminary phase I/II study results of orelabrutinib combined with MIL62 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Annals of Oncology. 32. S778–S778. 2 indexed citations
11.
Hu, Peng, et al.. (2021). Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies. Frontiers in Immunology. 12. 748585–748585. 9 indexed citations
12.
Song, Yuqin, Wei Xu, Yongping Song, et al.. (2020). Pooled Analysis of Safety Data from Clinical Trials of Orelabrutinib Monotherapy in Hematologic Malignancies. Blood. 136(Supplement 1). 43–43. 13 indexed citations
13.
Wang, Yajie, Peng Hu, Yan Wen, et al.. (2020). Traditional Chinese medicine compound, Bu Sheng Hui Yang Fang, promotes the proliferation of lymphocytes in the immunosuppressed mice potentially by upregulating IL-4 signaling. Biomedicine & Pharmacotherapy. 134. 111107–111107. 6 indexed citations
14.
15.
Qiao, Yan, Bin Zhou, Weijia Liu, et al.. (2016). A Novel Inhibitor of the Obesity-Related Protein FTO. Biochemistry. 55(10). 1516–1522. 84 indexed citations
16.
Zhang, Ying, Jun Ma, Qian Cao, et al.. (2015). The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation. PLoS ONE. 10(7). e0133788–e0133788. 89 indexed citations
17.
Zhao, Renbin, et al.. (2014). Effects of the replacement of corn oil with linseed oil on fatty acid composition and the expression of lipogenic genes in broiler chickens. Czech Journal of Animal Science. 59(8). 353–364. 10 indexed citations
18.
Dang, Li‐Zhi, et al.. (2012). Coenzyme Q10 enhances dermal elastin expression, inhibits IL‐1α production and melanin synthesis in vitro. International Journal of Cosmetic Science. 34(3). 273–279. 32 indexed citations
19.
Zhao, Renbin, Kurt Gish, Maureen E. Murphy, et al.. (2000). The Transcriptional Program following p53 Activation. Cold Spring Harbor Symposia on Quantitative Biology. 65(0). 475–482. 25 indexed citations
20.
Zhao, Renbin, Ann M. Lawler, & Se‐Jin Lee. (1999). Characterization of GDF-10 Expression Patterns and Null Mice. Developmental Biology. 212(1). 68–79. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doris A. Phelps Breakdown of academic impact, for papers by Susanne Meyer Breakdown of academic impact, for papers by Ge Zhou Breakdown of academic impact, for papers by Nigel J. O’Neil Breakdown of academic impact, for papers by Rosa Luna Breakdown of academic impact, for papers by Hestia Mellert Breakdown of academic impact, for papers by Elaine Sanij Breakdown of academic impact, for papers by Virginie Marcel Breakdown of academic impact, for papers by Jolly Mazumdar Breakdown of academic impact, for papers by Arnaud Coquelle
Rankless by CCL
2026